Pharma / Medical Technology

Interim Managing Director DACH

Medical technology / pharmaceutical industry
DACH region
International group of companies

The company’s DACH organization showed declining sales and revenue figures, and EBIT was clearly negative. A clear sales strategy was not in place, and internal cooperation with the product development, quality assurance and production departments was clearly strained.

Scroll to Top